Rapid Therapeutic Science Laboratories Inc (PCHA) Return on Assets ROA from the second quarter of 2023 to second quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Rapid Therapeutic Science Laboratories Inc   (PCHA)


Rapid Therapeutic Science Laboratories Inc 's ROA from the second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Rapid Therapeutic Science Laboratories Inc 's ROA in the second quarter of 2023?
Rapid Therapeutic Science Laboratories Inc achieved a return on average assets (ROA) of 3.12 % in its second quarter of 2023, this is above PCHA's average return on assets of -5913.28%.
Rapid Therapeutic Science Laboratories Inc assets over the 12 months ending in its second quarter of 2023 are valued at $2 million

Despite the company's net income deteriorating, Rapid Therapeutic Science Laboratories Inc was able to improve its ROA compared to the first quarter of 2023.

However, within the Healthcare sector 169 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2023 quarter, so far to 1782, from total ROA ranking in the first quarter of 2023 at 3122.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Total Assets Change 1.32 % -25.01 % -12.98 % -5.11 % 102.1 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 0 0 -2 -3 -3
Return On Assets (TTM) 3.12 % -1.25 % -87.82 % -144.61 % -159.51 %
PCHA's Total Ranking # 1782 # 3122 # 5765 # 5366 # 5517
Total Assets (TTM) in million 2 2 2 2 2
Seq. Total Assets Change 20.91 % -10.39 % -0.54 % -5.99 % -10.51 %
Seq. Net Income Change -75.73 % 290.84 % - - -

PCHA's 5 Years Annual ROA >> Back to PCHA Management Effectiveness >> Compare PCHA ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 62
Sector # 170
Overall # 1755

Return On Assets Statistics
High Average Low
2.75 %
-5913.28 %
-30297.15 %
(Jun 30 2023)   (Mar 31 2018)





Financial Statements
Rapid Therapeutic Science Laboratories Inc 's Assets $ 2 million PCHA's Balance sheet
Rapid Therapeutic Science Laboratories Inc 's Income $ 0 million Quarterly PCHA's Income Statement
PCHA's Income by Division See PCHA's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Mar 31 2020)
FY 2020		 (Mar 31 2019)
FY 2019		 (Mar 31 2018)
FY 2018
Y / Y Total Assets Change -12.98 % 394.82 % 32399.12 % -95.44 % 305.72 %
Total Assets in million 2 2 0 0 0
Y / Y Net Income Change - - - - -
Net Income in million -2 -3 -1 0 -3
Annual Return On Assets -93.75 % -130.36 % -140.49 % -25500.07 % -8508.86 %

PCHA's 5 Years Annual ROA >> Back to PCHA Management Effectiveness >> Compare PCHA ROA to its Competitors



More Return On Assets Ratios
PCHA's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PCHA's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PCHA's Competitors
Subscribers only: Roa for Rapid Therapeutic Science Laboratories Inc 's Suppliers
Subscribers only: Return On Assets for PCHA's Customers

You may also want to know
PCHA's Roi PCHA's Inventory Turnover Ratio PCHA's Growth Rates PCHA's Dividend Comparisons
PCHA's Profitability Ratios PCHA's Asset Turnover Ratio PCHA's Dividend Growth
PCHA's Roe PCHA's Valuation Ratios PCHA's Financial Strength Ratios PCHA's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2023, within Healthcare Sector ROA
Thorne Healthtech Inc   8.38 %
Bristol myers Squibb Company  8.34 %
Progyny Inc   8.27 %
Lemaitre Vascular Inc   8.05 %
Maravai Lifesciences Holdings Inc   7.63 %
Option Care Health Inc   7.60 %
Cadre Holdings inc   7.59 %
Omeros Corporation  7.54 %
Rennova Health Inc   7.52 %
Electromed Inc   7.44 %
Neurocrine Biosciences Inc   7.44 %
Patterson Companies Inc   7.37 %
Stryker Corp  7.37 %
Encompass Health Corporation  7.31 %
Haemonetics Corporation  7.17 %
Abbott Laboratories  7.01 %
Organon and Co   6.99 %
Johnson and Johnson  6.96 %
Ensign Group Inc  6.63 %
Quest Diagnostics Inc  6.56 %
Charles River Laboratories International inc   6.44 %
Abbvie Inc   6.32 %
Dexcom Inc   6.32 %
Incyte Corporation  6.28 %
Glucotrack Inc   6.11 %
Fonar Corporation  6.10 %
Staar Surgical Co  5.96 %
Lftd Partners Inc   5.93 %
Viemed Healthcare Inc   5.75 %
Addus Homecare Corp  5.75 %

Date modified: 2026-09-08T15:11:02+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.